FDA Updates Modified Risk Tobacco Product Orders for Swedish Match USA

Regulations by 2FIRSTS.ai

Jul.04.2024

FDA Updates Modified Risk Tobacco Product Orders for Swedish Match USA

FDA reissues two applications related to Swedish Match's General Snus products, extending public comment period for further review.

According to a news update on the official website of the US Food and Drug Administration (FDA) on July 3, FDA has reissued two application documents related to the Modified Risk Tobacco Product (MRTP) order for Swedish Match USA, Inc.'s General Snus products. These reissued documents contain previously edited content and are now available for viewing on the Swedish Match MRTP application webpage.

In addition, the FDA has extended the public comment period for the Swedish Match Company's MRTP update application to allow the public more time to review the recently reissued application materials. The public can submit comments on the application on the regulations.gov webpage with the docket number FDA-2014-N-1051. The FDA will announce the deadline for the comment period after it is determined.

These application materials have been edited in accordance with applicable laws and regulations and can be found on the FDA's website. Before making a final decision on the MRTP application, the FDA will consider all available information, including public comments and recommendations from the Tobacco Products Scientific Advisory Committee (TPSAC).

References:

[1] Swedish Match USA, Inc.’s Renewal MRTP Applications for General Snus Products: Materials Reposted, Comment Deadline Extended

Also Read:

[1] US Supreme Court Overturns Precedent, Impacting E-Cigarette Industry and FDA

[2] Supreme Court to Review FDA E-Cigarette Products Decision

[3] FDA Tobacco Product Center Updates Tobacco Compliance Inspection Results Database

[4] BAT Submits Final PMTA for Age Restriction Devices for Vuse Pro ENDS Device

[5] Altria Group Submits PMTA for on! PLUS Nicotine Pouches

#North America #United States #Traditional tobacco #Regulation #FDA #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT accused of “utter hypocrisy” over efforts to dilute Zambia’s tobacco bill

The Guardian reports that British American Tobacco urged Zambian ministers to drop or delay ad and sponsorship bans and to soften a draft tobacco bill by shrinking health warnings, easing flavour restrictions and lowering penalties. Critics said the stance is hypocritical given similar rules apply in the UK.

Nov.13

Lancashire Police Seize £200K Worth of Illegal Cigarettes and Vapes, Six Arrested

Lancashire Police seized nearly £200,000 worth of illicit cigarettes and vapes, arrested six suspects, and closed three shops under Operation Wanderstar. Raids on 22 premises across the county also uncovered counterfeit cash, hidden tobacco stashes, and frozen bank accounts linked to suspected money laundering.

Oct.29 by 2FIRSTS.ai

Ireland Considering Ban on Nicotine Pouches to Protect Youth, Says Chief Medical Officer

Ireland’s Department of Health is examining a ban on nicotine pouches to curb nicotine use among young people. Chief Medical Officer Prof. Mary Horgan said the ban could be included in amendments to the current tobacco bill.

Nov.10 by 2FIRSTS.ai

Nicoventures Granted Rehearing After Philip Morris Challenge Rejected

Nicoventures Trading Ltd., a subsidiary of British American Tobacco (BAT), has won an appeal at the European Patent Office (EPO), convincing the appellate board that examiners had violated its right to be heard by failing to review all of its submissions.